Related Experiment Video
Updated: May 3, 2026

An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse
Published on: September 12, 2018
Sources of variation in 133Xenon washout after subcutaneous injection on the abdomen
1Department of Clinical Physiology and Nuclear Medicine, Herlev Hospital, University of Copenhagen, Denmark.
Abstract:
The washout of 133Xenon injected locally in three subcutaneous regions on three volunteers was in a repeated latin square design analyzed regarding flow values and initial clearance. Blood flow showed no dependence on injected volumes (.02-.5 ml), but there was a significant day-day variation and regional and personal differences in subcutaneous blood flow. The initial fast washout was related to the injected volumes due to trauma and dilution of the tissue. From these results precautions are described to increase the validity of the local 133Xenon washout method for measurement of subcutaneous blood flow. In repeated clinical studies it remains important even on the same individuals to record sources of variation apart from the variable to be investigated.
Related Concept Videos
Compartment Models: Two-Compartment Model
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Non-Oral Extravascular Drug Absorption Routes
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

